Blocknomi
Key Takeaways Eli Lilly shares decline following announcement of $2.8B AtaiBeckley acquisition. Acquisition incorporates advanced-stage depression treatments into Lilly’s neuroscience division. Lead candidate BPL-003 progresses toward Phase 3 trials with…
Related articles
-
Broadcom (AVGO) Stock: Executive Dumps $10M in Shares — Red Flag or Routine Move?
Blocknomi Published 15.07.2026 10:47
-
Venom Foundation Seeks DeFi Insurance Partner to Strengthen On-Chain Security
BlockchainReporter Published 06.07.2026 10:30
-
ZachXBT sells copycat meme coins and donates $41K to charity
Crypto.News Published 06.07.2026 10:42
-
Bitcoin Mining Stocks Jump After TeraWulf Signs $19 Billion Lease With Anthropic
Decrypt Published 06.07.2026 15:15
-
Coinbase and Grayscale Executives Step Down After Major Crypto Wins
BeInCrypto Published 09.07.2026 22:05
-
Dell (DELL) Stock Soars 8% Following Trump’s Second Public Endorsement
Blocknomi Published 06.07.2026 14:51
-
Strategy (MSTR) Stock Surges 11% After CEO’s Insider Buy and New Capital Plan
Blocknomi Published 02.07.2026 12:14
-
'Literally a Crime': Cardano Creator Reacts to Ethereum's Next Big Innovation
U.Today Published 08.07.2026 09:58